Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results

Journal

2012 | 7 | 5 | 685-690

Article title

Impact of depression on multiple sclerosis patients

Content

Title variants

Languages of publication

EN

Abstracts

EN

Publisher

Journal

Year

Volume

7

Issue

5

Pages

685-690

Physical description

Dates

published
1 - 10 - 2012
online
28 - 7 - 2012

Contributors

  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Lithuania
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Lithuania

References

  • [1] Richards R.G., Sampson F.C., Beard S.M., Tappenden P., A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models, Health Tech. Assessment, 2002, 6, 1–73
  • [2] Rothwell P.M., Charlton D., High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition, J. Neurol. Neurosurg. Psychiatry, 1998, 64, 730–735 http://dx.doi.org/10.1136/jnnp.64.6.730[Crossref]
  • [3] Beiske A.G., Naess H., Aarseth J.H., Andersen O., Elovaara I., Farkkila M., et al., Health-related quality of life in secondary progressive multiple sclerosis, Mult. Scler., 2007, 13, 386–392 http://dx.doi.org/10.1177/13524585070130030101[Crossref]
  • [4] Sobocki P., Pugliatti M., Lauer K., Kobelt G., Estimation of the cost of MS in Europe: extrapolations from a multinational cost study, Mult. Scler., 2007, 13, 1054–1064 http://dx.doi.org/10.1177/1352458507077941[Crossref][WoS]
  • [5] Siegert R.J., Abernethy D.A., Depression in multiple sclerosis: a review, J. Neurol. Neurosurg. Psychiatry, 2005, 76, 469–475 http://dx.doi.org/10.1136/jnnp.2004.054635[Crossref]
  • [6] Nicholl C.R., Lincoln N.B., Francis V.M., Stephan T.F., Assessment of emotional problems in people with multiple sclerosis, Clin. Rehab., 2001, 15, 657–668 http://dx.doi.org/10.1191/0269215501cr427oa[Crossref]
  • [7] Stern M., Aging with multiple sclerosis, Phys. Med. Rehabil. Clin. N. Am., 2005, 16, 219–234 http://dx.doi.org/10.1016/j.pmr.2004.06.010[Crossref]
  • [8] Kurtzke J.F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 1983, 33, 1444–1452 http://dx.doi.org/10.1212/WNL.33.11.1444[Crossref]
  • [9] Simeoni M.C., Auquier P., Fernandez O., Flachenecker P., Stecchi S., Constantinescu C.S., et al., Validation of the multiple sclerosis international quality of life questionnaire, Mult. Scler., 2008, 14(2), 219–230 http://dx.doi.org/10.1177/1352458507080733[Crossref]
  • [10] Moran P.J., Mohr D.C., The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis, J. Behav. Med., 2005, 28(1), 35–41 http://dx.doi.org/10.1007/s10865-005-2561-0[Crossref]
  • [11] Zung W.W.K., A self-rating depression scale, Arch. Gen. Psych., 1965, 12, 63–70 http://dx.doi.org/10.1001/archpsyc.1965.01720310065008[Crossref]
  • [12] Friedman S., Even C., Samuelian J.C., Guelfi J.D., Factor structure of the Hospital Anxiety and Depression Scale, Br. J. Psychiatry, 2002, 181, 165–166
  • [13] Beck Depression Inventory - 2nd Edition, Available at http://www.ibogaine.desk.nl/graphics/3639b1c_23.pdf. 2008.
  • [14] Arnett P.A., Randolph J.J., Longitudinal course of depression symptoms in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 2006, 77, 606–610 http://dx.doi.org/10.1136/jnnp.2004.047712[Crossref]
  • [15] Galeazzi G.M., Ferrari S., Giaroli G., Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy, Neurol. Sci., 2005, 26, 255–262 http://dx.doi.org/10.1007/s10072-005-0468-8[Crossref]
  • [16] McGuigan C., Hutchinson M., Unrecognised symptoms of depression in a community-based population with multiple sclerosis, J. Neurol., 2006, 253, 219–223 http://dx.doi.org/10.1007/s00415-005-0963-0[Crossref]
  • [17] The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research, World Health Organsation, Geneva, 1993
  • [18] Lynch S.G., Kroencke D.C., Denney D.R., The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope, Mult. Scler., 2001, 7, 411–416 [Crossref]
  • [19] Chwastiak L.A., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H., Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample, Am. J. Psych., 2002, 159(11), 1862–1968 http://dx.doi.org/10.1176/appi.ajp.159.11.1862[Crossref]
  • [20] Buchanan R.J., Wang S., Tai-Seale M., Ju H., Analyses of nursing home residents with multiple sclerosis and depression using the Minimum Data Set, Mult. Scler., 2003, 9, 171–188 http://dx.doi.org/10.1191/1352458503ms872oa[Crossref]
  • [21] Sollom A.C., Kneebone I.I., Treatment of depression in people who have multiple sclerosis, Mult. Scler., 2007, 13, 632–635 http://dx.doi.org/10.1177/1352458507072384[Crossref]
  • [22] Beal C., Stuifbergen A.K., Sands D.V., Brown A., Depression in multiple sclerosis: a longitudinal analysis, Arch. Psychiatr. Nurs., 2007, 21, 181–191 http://dx.doi.org/10.1016/j.apnu.2007.02.008[WoS][Crossref]
  • [23] Pugliatti M., Sotgiu S., Rosati G., The worldwide prevalence of multiple sclerosis, Clin. Neurol. Neurosurg., 2002, 104, 182–191 http://dx.doi.org/10.1016/S0303-8467(02)00036-7[Crossref]
  • [24] Putzki N., Fischer J., Gottwald K. Reifschneider G., Ries S., Siever A., et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16(6), 713–720 http://dx.doi.org/10.1111/j.1468-1331.2009.02572.x[Crossref]
  • [25] Jongen P.J., Sindic C., Carton H. Zwanikken C., Lemmens W., Borm G., et al., Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a, J. Neurol., 2010, 257(4), 584–589 http://dx.doi.org/10.1007/s00415-009-5378-x
  • [26] Einarsson U., Gottberg K., Fredrikson S., von Koch L., Widén Holmqvist L., Activities of daily living and social activities in people with multiple sclerosis in Stockholm County, Clin. Rehabil., 2006, 20(6), 543–551 http://dx.doi.org/10.1191/0269215506cr953oa[Crossref]
  • [27] Pfleger C.C.H., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study, Mult. Scler., 2010, 16(7), 878–882 http://dx.doi.org/10.1177/1352458510370978[WoS][Crossref]
  • [28] Minden S.L., Mood disorders in multiple sclerosis: diagnosis and treatment, J. Neurovirol., 2000, 6(2), 160–167
  • [29] Gottberg K., Einarsson U., Ytterberg C., Fredrikson S., von Koch L, Holmqvist L.W., Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: a population-based study, Mult. Scler., 2008, 14(7), 962–971 http://dx.doi.org/10.1177/1352458508089688[Crossref]
  • [30] Koopman W.J., Benbow C.L., Vandervoort M., Top 10 needs of people with multiple sclerosis and their significant others, J. Neurosci. Nurs., 2006, 38, 369–373 http://dx.doi.org/10.1097/01376517-200610000-00008[Crossref]

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.-psjd-doi-10_2478_s11536-012-0032-x
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.